The Phase 2 Endpoint Dilemma

Applying AI And Rapid Prototyping To Media And Process Development

Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems

Translating Stem Cell Programs To GMP

The Future Of CGT: Integrating Digitalization With Regulatory Readiness

Four Common Pitfalls To Avoid In UF/DF Setup And Scale-Up

Bridging Discovery And CMC With Rapid Pools

Charting The Path To First-In-Human: Strategic Readiness For Early Clinical Success

Selecting A Prefillable Syringe System With Confidence

Simplified Harvest And Media Exchange In Cell Therapy

Next-Level Cell Lines: An Integrated Approach To Biologic Innovation

DynaDrive S.U.B. Video Series

DynaDrive Single-Use Bioreactors Drilled-Hole Sparge Technology

DynaDrive Single-Use Bioreactors - One Reactor, Many Volumes

Scale With Confidence From Bench To Commercial Production

Why Is The Bioreactor Square? The Geometry Behind Exceptional Mixing

Aegis Film For DynaDrive Single-Use Bioreactors

Applying AI And Rapid Prototyping To Media And Process Development

Five Reasons To Choose Thermo Scientific DynaDrive Single-Use Bioreactors

Go Beyond Custom Media Screening And Prototyping

Take The Lead With The Gibco CHOvantage™ GS Cell Line Development Kit

From Lab To Commercialization: Simplifying Bioprocess Scale-Up

Smart Media Screening And Design: Saving Time And Boosting Titers

Introducing The Applied Biosystems Resdnaseq Quantitative DNA System

Efficient-Pro Medium And Feed Marketing

Inside Bioprocessing: Next Generation CHO Media And Feeds

Practical Solutions For Protein Analytics And Residual DNA Testing

Enabling Assurance Of Supply Through Evolving Bioprocessing Needs

Cytovance And Thermo Fisher Scientific Single-Use Equipment Collaboration

HyPerforma DS 300 Single-Use Mixer Overview

A Straightforward Path Toward Regulatory Compliance & Data Integrity With Your Microbial Testing Systems

Boosting Vaccine Yields Through Smarter Cell Culture Media Optimization

Driving Sustainability In Bioprocessing With Biobased Single-Use Solutions

Interview With Pharma Analytics Field Application Specialist - Sandi True

Interview With Nico Chow And Sandi True, Field Applications Specialists

Leveraging Single-Use Bioreactors In Bench-Scale Process Development

A CDMO Perspective: Bioprocess Automation And Data Management

Dry Powder Media Manufacturing Grand Island Expansion

Accelerating Process Scale-Up From Benchtop To Commercialization- From Controller To Software

CaptureSelect™ Technology - Powerful Affinity For More Streamlined Purification

CaptureSelect Affinity Chromatography

Multi-Omics In Cell Culture Media Design

Supply Chain Efficiency And Sourcing In Gene Therapy

Inside Bioprocessing: Microbial Media

Basic Cell Culture Education Series: CHO Media

Optimization Of Anion Exchange Purification For The Large-Scale Production Of Plasmid DNA

Inside Bioprocessing: Continuous Perfusion

Cell Culture Media Manufacturing, Paisley, Scotland

Cell Culture Media Manufacturing, Grand Island, NY

Single-Use Assembly Configurator Tutorial

An All-In-One Solution For Residual DNA Quantitation

GLP And The Impact To Start Up Companies

Elucidating The Role Of IL-18 In NSCLC Integrated Analysis

Is The Sensitivity Of Optical Biosensors Important?

Can Kinetics Provide Detailed Information About Binding Interactions?

Achieving Stability For mRNA

Why Material Definitions Matter In Cell And Gene Therapy

How To Best Optimize mRNA Production Workflows

Non-Viral Tools For Genome Engineering

Safety And Efficacy Advancements In Genome Editing

Saudi Arabia Government Leaders Discuss Agile Manufacturing Beyond Borders

Regulatory Flexibility in CGT: Key Shifts and Implications with Monika Swietlicka

Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye

Simplifying Friction in Cell Therapy Clinical Trials with Dr. Panteli Theocharous

Inside a Breakthrough HER2 Immunotherapy for PMO with OS Therapies' Paul Romness

Building Safer CRISPR Medicines for CVD with Scribe Therapeutics' Benjamin Oakes

Advancing Off-The-Shelf CRISPR CAR-T Therapies Into The Community Setting With Caribou Biosciences' Rachel Haurwitz

The Editors' Roundtable: A 2025 Retrospective of the Life Sciences Industry

Developing Itvisma for Broad-Range Treatment of SMA with Novartis' Dr. Norman Putzki

Turning the Tumor Microenvironment Against Cancer with MGB's Alexander Cryer, Ph.D.

Building Patient-Driven Culture and Leadership Resilience in CGT with Paul Perreault

Treating Inherited Retinal Disorders with Ocugen's Dr. Arun Upadhyay

Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer

Emerging Manufacturing Technologies For Cell Therapies | Audience Q&A

Detecting Mycoplasma Contamination In Your Cell Culture

Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility

Invetech Cell & Gene Tech Expo April 2025: Cell Therapy

Discover The Benchtop DynaDrive Single-Use Bioreactor

Scale With Confidence From Bench To Commercial Production

Cell Insights By Umetrics® Studio

Introducing Our Single Use Mixing System

Automated Bioburden Testing Solution

Freezing Studies For Single-Use Solutions: Therapy Containment/Protection (Part 3)

Freezing Studies For Single-Use Solutions: Transportation (Part 4)

Biopharma Resilience: Building Biomanufacturing Capacity

A Concept-To-Commercial Gene Therapy CDMO

The Power Of Partnerships And The Rise Of iPSC

Early-Phase Whole-Body PK

What Is Causing Limited Bioavailability

Biopharma Resilience: Bionova Scientific Talks Capacity, Speed, And Agility

Closing Ancillary Processes: The New Bottleneck In Cell and Gene Therapy

Selecting The Right CMO For Your Gene Therapy

Supply Chain And Operational Challenges Facing mRNA

Thermo Fisher Scientific Single-Use Global Manufacturing Network

Robust And Consistent Frozen Storage And Shipment

Biopharma Supply, Reimagined: Blarney, A Climate-Neutral Facility For Best-In-Class Filters

Risk Mitigation Strategies

Balancing Innovation With Manufacturability When GMP-Grade Is Unavailable

Bridging The Gap Between Lab Development And GMP Manufacturing

Optimizing Your Cold Chain For Cell Therapies | Audience Questions

Bioprocessing Solutions For Cell Culture

Storing Your Banks With Ease And Confidence

Supporting The Global Biopharma Industry With Single-Use Capacity Expansion

Comparing Manual Vs. Automated Processing And Thawing Systems

Accelerate Innovation With Compliant Software Solutions

Visual Inspection Of Advanced Therapy Medicinal Products

Boost Compliance And Efficiency With Real-Time Asset Management

Ensuring The Safety Of Cell Therapy Manufacturing Through Quality Control Solutions

Is Your Current AAV Process Holding You Back?

PEI And Non-PEI Transfection Solutions For High Titers And Production

CellShot PFEP™ + Proliva™: Enhancing Post-EP Proliferation

How CRISPR And LNP Accelerate Therapeutic Innovation Through Analytics

Addressing Core Requirements In CGT Manufacturing Optimization

Navigating Challenging Cell Engineering Workflows With A Scalable, Proven Electroporation Platform

Non-Viral Delivery Of Complex Cargos For Large-Scale T-Cell Manufacturing

Accelerate Manufacturing With GMP-Compliant Automation Solutions

Materials Matter: Ensuring Quality Of CGT Materials

Building Smarter Cell Therapies With AI And Synthetic Biology

2026 Regulatory Roadmap

Driving Efficiency, Reducing Costs In Multi-Modal CGT Manufacturing

Viability On The Line: Defining Minimum Quality For CGT Raw Materials

Designing Early Manufacturing For Long-Term Success In CGT

Building The Future Of Cancer Immunotherapy Through Allogeneic NK Cell Innovation

Redefining CGT With Exosomes And EVs

Advancing Gene Delivery: LNPs, Adenovirus, Lentivirus, And More

Unlocking The Potential Of iPSC Therapies In Regenerative Medicine

Emerging Manufacturing Technologies For Cell Therapies

Optimizing Storage Solutions For Allogeneic iPSCs

2025 CGT Regulatory Outlook

Unlocking The Full Potential Of AAV-Mediated Gene Delivery

Inside The Most Promising Non-Viral Approaches For Genetic Engineering

From Bottleneck To Breakthrough: Reimagining The mRNA Therapeutics Supply Chain

Modernizing CAR-T Manufacturing: Is Point Of Care The Future?

Top Strategies To Reduce Off-Target Effects For Safer Genome Editing

Inside Next-Gen Platforms For Cell Therapy Manufacturing

Unlocking The Future Of Allogeneic Cell Therapy For Oncology

Stem-Cell Derived Therapies: From Source To Site

How To Reduce Batch-to-Batch Variation In Cell Therapy Manufacturing

2024 Regulatory Outlook With FDA's Drs. Peter Marks And Nicole Verdun

Considerations For Investing In Your Gene Therapy's Automation Framework

mRNA For Cancer Immunotherapy: 2024 Outlook

Are We There Yet? Roadmap(s) To Higher Quality AAV

Optimizing Your Cold Chain For Cell Therapies

Stability To Scalability: The Future Of Viral Vector Therapies

Regulating The CGT Workflow To Improve Patient Safety

Driving Down COGS: Automation's Role In Cell Therapy Manufacturing

Major Trends In Next-Gen RNA Engineering

Building An In-House Cell & Gene Manufacturing Facility: Best Practices & Lessons Learned

Scaling Cell Therapies Part 2: Establishing Comparability In Manufacturing

Tackling Cell And Gene Therapies' Top 3 Regulatory Impediments

Evaluating Translational Research Tools For CGTs

Scaling Cell Therapies: Auto vs. Allo

Advancements In Targeted mRNA Delivery

Win The CGT Talent Fight: How To Find And Retain Experts

Kite Pharma's Ultimate Supply Chain Test - A Q&A With Their 4-Exec Panel On Overcoming The Pandemic's Disruption

The Therapeutic Potential Of Exosomes

The Future of CRISPR-Engineered Stem Cell Therapies

Regulatory Challenges And Future Outlook For iPSC Therapies

A CDMO Perspective: Bioprocess Automation And Data Management

Strategies To Reduce Regulatory Risks In Gene Therapy

2025 CGT Regulatory Outlook | Audience Q&A

CGT's Main Opportunities To Meet Regulatory Requirements

How The FDA Strengthens Industry Collaboration

MilliporeSigma Bio-Expo Live February 2025: Upstream Bioprocessing

How The FDA's 2024 Draft Guidances Will Influence CGT Regulation In 2025

Tackling Cell And Gene Therapies' Top 3 Regulatory Impediments: Audience Q&A

Simplifying Bioprocess Data Collection

Dr. Peter Marks Talks a Standardized Playbook for Gene Therapy Manufacturing

Ensuring Consistent Removal Of Residual Impurities

Bridging Analytical Gaps To Ensure CGT Material Quality

Challenge #3: Lack Of Animal Models

How The New Administration Could Shape FDA Oversight, Compliance, And Guidance In 2025

How Past Gene Therapy Approvals Are Shaping the Future with Dr. Peter Marks

Lower Variability For Viral Titer Determination

Other CGT Regulatory Challenges

Prioritizing Quality, Fit, And Supplier Reliability In CGT Materials

Congruence And Divergence In Global Regulatory Approvals

Challenge #1: The Changing Regulatory Landscape

Navigating Global Regulations, Equity Challenges, And The Future Of Patient Access

Cell And Gene Therapy Innovations

Focal Points for 2024: Dr. Verdun and Dr. Marks Talk Regulatory Challenges for Cell-Based Therapies

Race To The Regulatory Finish Line: Dr. Nicole Verdun Talks Efficiencies In Platform Technologies

mRNA For Cancer Immunotherapy 2024 Outlook | Audience Q&A

Future Proof Process Design Through Risk-Focused Decisions, Automation Readiness, And Regulatory Pragmatism

Assessing Residuals In Processing And Fill/Finish For iPSCs

Challenge #2: Rare Or Ultra-Rare Study Design Considerations And Use Of Existing Data

Executive Roundtable: Cell Therapy Predictions For 2025 And Beyond

A Straightforward Path Toward Regulatory Compliance & Data Integrity With Your Microbial Testing Systems

Key Regulatory Challenges, Innovations, And Opportunities For CGT In 2025

Patient Data's Impact On CMC Robustness

Mitigate Clinical Risk In Cell Therapy Development With A GMP Compliant Process

Master The 2-Point Calibration Process To Maintain Data Integrity

Why Clinical Requirements Change: Dr. Peter Marks on Pre-IND Meeting Pathways

Making USP Guidance Actionable For CGT Materials

Inside The Phased, Risk-Based Approach For CGT Materials

What's New for 2024: Dr. Nicole Verdun Offers a Look Inside The Office Of Therapeutic Products

CMC Comparability: Transitioning to Commercial Manufacturing with Dr. Nicole Verdun

Investing In Early-Stage Oncology With Yosemite's Dan McHugh

Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash

Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.

Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.

Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.

An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.

Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer

Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

BoB@JPM: Brian Hilberdink, Boehringer Ingelheim

BoB@JPM: Ron Cooper, enGene

BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics

A Royalty Model For Value Creation With Zymeworks' Kenneth Galbraith

Scaling Regenerative Medicine Production With PolarityBio's Nikolai Sopko, MD, Ph.D.

Pursuing Quality While Maintaining Process Control With Richard Moroney, Ph.D.

Unlocking The Therapeutic Power Of Fibroblasts With Pete O'Heeron And Hamid Khoja, Ph.D.

Supporting The Bioprocessing Workforce In The AI Era With Sanofi's Eric Doerr

Putting Pressure On CDMOs With Herman Bozenhardt

Data Governance And Regulations For AI Use In GMP With Peter Baker

The Editors' Roundtable: A 2025 Retrospective Of The Life Science Industry

Combining AI With Operations Research To Advance Biomanufacturing With Tinglong Dai, Ph.D., and Tugce Martagan, Ph.D.

Building An Oral Vaccine Platform With Vaxart's Sean Tucker, Ph.D.

Lessons In Scaling Regenerative Medicine Manufacturing With Organogenesis's Patrick Bilbo

Navigating The Complexity of Conditionally Active Biologics With Bonum Therapeutics' Diane Hollenbaugh, Ph.D., and Neela Patel, Ph.D.

Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.